BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30601876)

  • 1. Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas.
    Klebanov N; Lin WM; Artomov M; Shaughnessy M; Njauw CN; Bloom R; Eterovic AK; Chen K; Kim TB; Tsao SS; Tsao H
    JAMA Dermatol; 2019 Feb; 155(2):211-215. PubMed ID: 30601876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas.
    Francis JH; Milman T; Grossniklaus H; Albert D; Folberg R; Levitin G; Coupland S; Catalanotti F; Rabady D; Kandoth C; Busam K; Abramson D
    Ophthalmology; 2019 May; 126(5):759-763. PubMed ID: 30537484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.
    Liau JY; Lee JC; Tsai JH; Chen CC; Chung YC; Wang YH
    Mod Pathol; 2019 Nov; 32(11):1657-1665. PubMed ID: 31189994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.
    Ayturk UM; Couto JA; Hann S; Mulliken JB; Williams KL; Huang AY; Fishman SJ; Boyd TK; Kozakewich HP; Bischoff J; Greene AK; Warman ML
    Am J Hum Genet; 2016 Apr; 98(4):789-95. PubMed ID: 27058448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent GNAQ mutations in anastomosing hemangiomas.
    Bean GR; Joseph NM; Gill RM; Folpe AL; Horvai AE; Umetsu SE
    Mod Pathol; 2017 May; 30(5):722-727. PubMed ID: 28084343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma.
    Bichsel CA; Goss J; Alomari M; Alexandrescu S; Robb R; Smith LE; Hochman M; Greene AK; Bischoff J
    JAMA Ophthalmol; 2019 Jan; 137(1):91-95. PubMed ID: 30422215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent GNAQ and GNA14 Mutations in Hepatic Small Vessel Neoplasm.
    Joseph NM; Brunt EM; Marginean C; Nalbantoglu I; Snover DC; Thung SN; Yeh MM; Umetsu SE; Ferrell LD; Gill RM
    Am J Surg Pathol; 2018 Sep; 42(9):1201-1207. PubMed ID: 29975248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNAQ Q209R Mutations Are Highly Specific for Circumscribed Choroidal Hemangioma.
    Le Guin CHD; Metz KA; Kreis SH; Bechrakis NE; Bornfeld N; Zeschnigk M; Lohmann DR
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cherry Angiomas-Further Expanding the Phenotype With Somatic GNAQ and GNA11 Mutations.
    Siegel DH
    JAMA Dermatol; 2019 Feb; 155(2):148-149. PubMed ID: 30601884
    [No Abstract]   [Full Text] [Related]  

  • 11. Tufted angioma with associated Kasabach-Merritt phenomenon caused by somatic mutation in GNA14.
    Lim YH; Fraile C; Antaya RJ; Choate KA
    Pediatr Dermatol; 2019 Nov; 36(6):963-964. PubMed ID: 31423605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis.
    Tse JY; Walls BE; Pomerantz H; Yoon CH; Buchbinder EI; Werchniak AE; Dong F; Lian CG; Granter SR
    J Cutan Pathol; 2016 Jan; 43(1):57-63. PubMed ID: 26260725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
    Emley A; Nguyen LP; Yang S; Mahalingam M
    Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.
    Liau JY; Tsai JH; Lan J; Chen CC; Wang YH; Lee JC; Huang HY
    Virchows Arch; 2020 Mar; 476(3):475-481. PubMed ID: 31707589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
    Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.